United States · Platforms & data · MarketBeat

PTC Therapeutics (NASDAQ:PTCT) to Buy Back $500 million in Outstanding Stock

Published by MarketBeat · United States 1 h ago

PTC Therapeutics (NASDAQ:PTCT - Get Free Report) announced that its Board of Directors has approved a stock buyback program on Tuesday, November 3rd, RTT News reports. The company…

Read the full article on MarketBeat Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)

Also worth reading

Seeking Alpha

Arista forecasts $18.5B FY 2027 revenue amid 38%-40% growth outlook and $7B AI fabrics target

The Motley Fool

PTC Therapeutics (NASDAQ:PTCT) to Buy Back $500 million in Outstanding Stock

Share

Also worth reading

Arista forecasts $18.5B FY 2027 revenue amid 38%-40% growth outlook and $7B AI fabrics target

ADT: 3 Key Takeaways for Long-Term Investors

Market analysts react to US midterm election results

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

Texas governor race tightens in prediction markets, but Abbott remains favored

Market News